Relationship of Self-reported and Performance-based Visual Function With Performance-based Measures of Physical Function: The Health ABC Study.


Journal

The journals of gerontology. Series A, Biological sciences and medical sciences
ISSN: 1758-535X
Titre abrégé: J Gerontol A Biol Sci Med Sci
Pays: United States
ID NLM: 9502837

Informations de publication

Date de publication:
28 10 2023
Historique:
received: 21 04 2022
medline: 30 10 2023
pubmed: 9 11 2022
entrez: 8 11 2022
Statut: ppublish

Résumé

To assess the relationship between self-reported and performance-based visual impairment (VI) and lower extremity physical function. Cross-sectional analysis of 2 219 Health ABC participants who completed vision testing and the Short Physical Performance Battery (SPPB). Linear regression models used either self-reported (weighted visual function question [VFQ] score) or performance-based (visual acuity [VA], log contrast sensitivity [LCS], Frisby stereoacuity [SA]) to predict SPPB or its components-gait speed, chair stands, or standing balance-with and without covariate adjustment. Mean age was 73.5 years (range 69-80); 52.4% were female and 37.4% African American. All VI measures were strongly associated with SPPB in unadjusted and adjusted models (p < .001). A self-reported VFQ score 1 standard deviation lower than the mean (mean 87.8 out of 100) demonstrated a -0.241 (95% confidence interval [CI]: -0.325, -0.156) adjusted difference in SPPB. After controlling for covariates, VA of <20/40 (41%) demonstrated a -0.496 (-0.660, -0.331) lower SPPB score while SA score>85 arcsec (30%) had a -0.449 (-0.627, -0.271) adjusted SPPB score versus those with better visual function. LCS < 1.55 (28.6%) was associated with a -0.759 (-0.938, -0.579) lower and LCS ≤ 1.30 (8%) with a -1.216 (-1.515, -0.918) lower adjusted SPPB score relative to better LCS. In a final multivariable model containing multiple vision measures, LCS remained independently associated with SPPB and all components, while SA remained associated with balance (all p < .05). Both self-reported and performance-based VI are strongly associated with poor lower extremity physical function. These findings may identify a subgroup of older adults with co-existing visual and physical dysfunction who may benefit from targeted screening and intervention to prevent disability.

Sections du résumé

BACKGROUND
To assess the relationship between self-reported and performance-based visual impairment (VI) and lower extremity physical function.
METHODS
Cross-sectional analysis of 2 219 Health ABC participants who completed vision testing and the Short Physical Performance Battery (SPPB). Linear regression models used either self-reported (weighted visual function question [VFQ] score) or performance-based (visual acuity [VA], log contrast sensitivity [LCS], Frisby stereoacuity [SA]) to predict SPPB or its components-gait speed, chair stands, or standing balance-with and without covariate adjustment.
RESULTS
Mean age was 73.5 years (range 69-80); 52.4% were female and 37.4% African American. All VI measures were strongly associated with SPPB in unadjusted and adjusted models (p < .001). A self-reported VFQ score 1 standard deviation lower than the mean (mean 87.8 out of 100) demonstrated a -0.241 (95% confidence interval [CI]: -0.325, -0.156) adjusted difference in SPPB. After controlling for covariates, VA of <20/40 (41%) demonstrated a -0.496 (-0.660, -0.331) lower SPPB score while SA score>85 arcsec (30%) had a -0.449 (-0.627, -0.271) adjusted SPPB score versus those with better visual function. LCS < 1.55 (28.6%) was associated with a -0.759 (-0.938, -0.579) lower and LCS ≤ 1.30 (8%) with a -1.216 (-1.515, -0.918) lower adjusted SPPB score relative to better LCS. In a final multivariable model containing multiple vision measures, LCS remained independently associated with SPPB and all components, while SA remained associated with balance (all p < .05).
CONCLUSIONS
Both self-reported and performance-based VI are strongly associated with poor lower extremity physical function. These findings may identify a subgroup of older adults with co-existing visual and physical dysfunction who may benefit from targeted screening and intervention to prevent disability.

Identifiants

pubmed: 36346340
pii: 6809301
doi: 10.1093/gerona/glac225
pmc: PMC10613017
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

2060-2069

Subventions

Organisme : NIA NIH HHS
ID : R01 AG052419
Pays : United States
Organisme : NINR NIH HHS
ID : R01 NR012459
Pays : United States
Organisme : NEI NIH HHS
ID : K23 EY030897
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG021332
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG028050
Pays : United States
Organisme : NINR NIH HHS
ID : R01 NR012459
Pays : United States

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of The Gerontological Society of America. 
All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

J Gerontol A Biol Sci Med Sci. 2000 Apr;55(4):M221-31
pubmed: 10811152
Invest Ophthalmol Vis Sci. 2003 Feb;44(2):891-900
pubmed: 12556426
Invest Ophthalmol Vis Sci. 2006 Jan;47(1):65-71
pubmed: 16384945
Am J Ophthalmol. 2010 Feb;149(2):330-40
pubmed: 20103058
Arch Ophthalmol. 2002 Jun;120(6):774-80
pubmed: 12049583
J Am Geriatr Soc. 1994 Mar;42(3):287-92
pubmed: 8120313
Int Urogynecol J. 2022 Oct;33(10):2815-2824
pubmed: 34379165
Transl Vis Sci Technol. 2021 Dec 1;10(14):15
pubmed: 34913953
Aging Clin Exp Res. 2004 Oct;16(5):382-8
pubmed: 15636464
Ophthalmic Physiol Opt. 1990 Jan;10(1):21-4
pubmed: 2330208
Ophthalmology. 1998 Jan;105(1):160-4
pubmed: 9442793
Br J Ophthalmol. 2006 Jan;90(1):91-5
pubmed: 16361675
J Gerontol A Biol Sci Med Sci. 2007 Nov;62(11):1244-51
pubmed: 18000144
JAMA Ophthalmol. 2021 Oct 01;139(10):1053-1060
pubmed: 34292297
J Gerontol A Biol Sci Med Sci. 2011 Jan;66(1):89-96
pubmed: 20861145
Arch Ophthalmol. 2001 Jul;119(7):1050-8
pubmed: 11448327
J Am Geriatr Soc. 2005 Oct;53(10):1675-80
pubmed: 16181165
JAMA Ophthalmol. 2016 Jul 1;134(7):802-9
pubmed: 27197072
J Aging Phys Act. 2018 Apr 1;26(2):235-247
pubmed: 28714802
Age Ageing. 2006 Sep;35 Suppl 2:ii42-ii45
pubmed: 16926203
J Am Geriatr Soc. 2006 May;54(5):743-9
pubmed: 16696738
Arch Ophthalmol. 2006 Feb;124(2):243-9
pubmed: 16476894
Trans Am Ophthalmol Soc. 2003;101:191-6; discussion 196-9
pubmed: 14971577
Optom Vis Sci. 2004 May;81(5):298-307
pubmed: 15181354
Arch Gerontol Geriatr. 2009 Jul-Aug;49(1):22-6
pubmed: 18513808
J Gerontol. 1994 Mar;49(2):M85-94
pubmed: 8126356
Ophthalmology. 2021 Jan;128(1):70-77
pubmed: 32615202
Am J Optom Physiol Opt. 1976 Nov;53(11):740-5
pubmed: 998716
BMC Ophthalmol. 2006 Jun 09;6:24
pubmed: 16764714
J Gerontol A Biol Sci Med Sci. 2001 Oct;56(10):M644-9
pubmed: 11584038
J Am Geriatr Soc. 2015 Jan;63(1):46-54
pubmed: 25536849
Invest Ophthalmol Vis Sci. 2001 Jan;42(1):64-72
pubmed: 11133849
Am J Epidemiol. 2000 Oct 1;152(7):633-9
pubmed: 11032158
Clin Exp Optom. 2006 Jul;89(4):215-28
pubmed: 16776729
Invest Ophthalmol Vis Sci. 1997 Jan;38(1):72-82
pubmed: 9008632
Optom Vis Sci. 1998 Jul;75(7):538-47
pubmed: 9703043
N Engl J Med. 1995 Mar 23;332(12):767-73
pubmed: 7862179
J Clin Endocrinol Metab. 2005 May;90(5):2787-93
pubmed: 15728213
Ophthalmic Epidemiol. 1999 Mar;6(1):49-60
pubmed: 10384684
Invest Ophthalmol Vis Sci. 2013 Nov 19;54(12):7683-90
pubmed: 24176902
Ophthalmic Epidemiol. 2017 Dec;24(6):364-370
pubmed: 28346032
Invest Ophthalmol Vis Sci. 2018 Jan 1;59(1):289-297
pubmed: 29340643
Invest Ophthalmol Vis Sci. 2011 Sep 09;52(10):7168-74
pubmed: 21862652
J Am Geriatr Soc. 2008 Aug;56(8):1417-23
pubmed: 18808598
Age Ageing. 2010 Mar;39(2):239-45
pubmed: 20065356
Optom Vis Sci. 2005 Feb;82(2):87-93
pubmed: 15711455
Am J Optom Physiol Opt. 1982 May;59(5):413-26
pubmed: 7102800
Lancet Glob Health. 2021 Feb;9(2):e144-e160
pubmed: 33275949
J Gerontol A Biol Sci Med Sci. 2009 Jan;64(1):61-8
pubmed: 19164276
Arch Phys Med Rehabil. 2011 Jul;92(7):1074-9
pubmed: 21704787

Auteurs

Atalie C Thompson (AC)

Department of Surgical Ophthalmology, Wake Forest University School of Medicine, Winston Salem, North Carolina, USA.
Section on Gerontology and Geriatric Medicine, Wake Forest University School of Medicine, Winston Salem, North Carolina, USA.

Michael E Miller (ME)

Section on Gerontology and Geriatric Medicine, Wake Forest University School of Medicine, Winston Salem, North Carolina, USA.
Division of Public Health Sciences, Wake Forest University School of Medicine, Winston Salem, North Carolina, USA.

Christopher C Webb (CC)

Department of Surgical Ophthalmology, Wake Forest University School of Medicine, Winston Salem, North Carolina, USA.
Department of Biostatistics and Data Science, Wake Forest University School of Medicine, Winston Salem, North Carolina, USA.

Jeff D Williamson (JD)

Department of Surgical Ophthalmology, Wake Forest University School of Medicine, Winston Salem, North Carolina, USA.
Section on Gerontology and Geriatric Medicine, Wake Forest University School of Medicine, Winston Salem, North Carolina, USA.

Stephen B Kritchevsky (SB)

Section on Gerontology and Geriatric Medicine, Wake Forest University School of Medicine, Winston Salem, North Carolina, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH